Drugs that contain Alendronate Sodium; Cholecalciferol
1. Fosamax Plus D patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6090410 | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Dec, 2012
(11 years ago) | |
| US5681590 | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Dec, 2012
(11 years ago) | |
| US5358941 | ORGANON LLC | Dry mix formulation for bisphosphonic acids with lactose |
Dec, 2012
(11 years ago) | |
|
US6090410 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Jun, 2013
(10 years ago) | |
|
US5358941 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids with lactose |
Jun, 2013
(10 years ago) | |
|
US5681590 (Pediatric) | ORGANON LLC | Dry mix formulation for bisphosphonic acids |
Jun, 2013
(10 years ago) | |
| US5994329 | ORGANON LLC | Method for inhibiting bone resorption |
Jul, 2018
(5 years ago) | |
|
US5994329 (Pediatric) | ORGANON LLC | Method for inhibiting bone resorption |
Jan, 2019
(5 years ago) | |
Market Authorisation Date: 07 April, 2005
Treatment: Treatment of osteoporosis in post menopausal women and/or the treatment to increase bone mass in men with osteoporosis
Dosage: TABLET;ORAL
How can I launch a generic of FOSAMAX PLUS D before it's drug patent expiration?
More Information on Dosage
FOSAMAX PLUS D family patents
